[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE8605513D0 - NEW PEPTID AND IMMUNOLOGICALLY ACTIVE ASSOCIATIONS - Google Patents

NEW PEPTID AND IMMUNOLOGICALLY ACTIVE ASSOCIATIONS

Info

Publication number
SE8605513D0
SE8605513D0 SE8605513A SE8605513A SE8605513D0 SE 8605513 D0 SE8605513 D0 SE 8605513D0 SE 8605513 A SE8605513 A SE 8605513A SE 8605513 A SE8605513 A SE 8605513A SE 8605513 D0 SE8605513 D0 SE 8605513D0
Authority
SE
Sweden
Prior art keywords
arg
peptid
ser
new
immunologically active
Prior art date
Application number
SE8605513A
Other languages
Swedish (sv)
Other versions
SE468716B (en
SE8605513L (en
Inventor
T Bartfai
Original Assignee
Trion Forskning & Utveckling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trion Forskning & Utveckling filed Critical Trion Forskning & Utveckling
Priority to SE8605513A priority Critical patent/SE468716B/en
Publication of SE8605513D0 publication Critical patent/SE8605513D0/en
Priority to SE8700761A priority patent/SE457353B/en
Priority to EP87850394A priority patent/EP0279151B1/en
Priority to DE8787850394T priority patent/DE3785664T2/en
Priority to US07/375,004 priority patent/US5283321A/en
Priority to PT86423A priority patent/PT86423B/en
Priority to AU10891/88A priority patent/AU616649B2/en
Priority to IE873470A priority patent/IE873470L/en
Priority to AT87850394T priority patent/ATE88719T1/en
Priority to JP63500766A priority patent/JP2635742B2/en
Priority to PCT/SE1987/000619 priority patent/WO1988004665A1/en
Publication of SE8605513L publication Critical patent/SE8605513L/en
Priority to DK392188A priority patent/DK392188A/en
Priority to NO883697A priority patent/NO883697D0/en
Priority to FI892985A priority patent/FI892985A/en
Publication of SE468716B publication Critical patent/SE468716B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The patent describes a peptide of the formula NH2-X1-Gln-Thr-Arg-Ala-Asn-Pro-Asn-Pro-Tyr-Thr- -Ser-Arg-Arg-Ser-Val-Ala-Ser-X2-COY in which X1 and X2 each represents a possible amino acid coupling unit, and Y represents -OH or -NH2, and an artificially prepared compound in free or carrier- associated form having the ability to bind to glycoconjugates, especially immunoglobulins, which compound is selected from the group which consists of the said peptide and functional analogues and functional derivatives thereof.
SE8605513A 1986-12-22 1986-12-22 Novel peptide and immunologically active compounds SE468716B (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE8605513A SE468716B (en) 1986-12-22 1986-12-22 Novel peptide and immunologically active compounds
SE8700761A SE457353B (en) 1986-12-22 1987-02-24 PERTUSSISTOXIN ANTIGEN APPLIES IMMUNAL ANALYSIS TEST RATE, VACCINE COMPOSITION AND INTRADERMAL SKIN TEST COMPOSITION WITH THE SAME ANTIGEN
PCT/SE1987/000619 WO1988004665A1 (en) 1986-12-22 1987-12-21 A new pertussis toxin derived polypeptide and applications thereof
AU10891/88A AU616649B2 (en) 1986-12-22 1987-12-21 A new pertussis toxin derived polypeptide and applications thereof
JP63500766A JP2635742B2 (en) 1986-12-22 1987-12-21 Novel polypeptide and its use
US07/375,004 US5283321A (en) 1986-12-22 1987-12-21 Polypeptide compound which binds to glyco-conjugates and to artificial pertussis toxin antigen
PT86423A PT86423B (en) 1986-12-22 1987-12-21 A process for the preparation of a novel polypeptide and its applications in immunology
EP87850394A EP0279151B1 (en) 1986-12-22 1987-12-21 Pertussis toxin polypeptide and its uses
IE873470A IE873470L (en) 1986-12-22 1987-12-21 A new polypeptide and applications thereof
AT87850394T ATE88719T1 (en) 1986-12-22 1987-12-21 PERTUSSIS TOXIN POLYPEPTIDE AND ITS APPLICATIONS.
DE8787850394T DE3785664T2 (en) 1986-12-22 1987-12-21 PERTUSSIS TOXIN POLYPEPTIDE AND ITS APPLICATIONS.
DK392188A DK392188A (en) 1986-12-22 1988-07-12 AN UNKNOWN POLYPEPTYD MADE FROM A PERTUSSIS TOXIN AND APPLICATIONS THEREOF
NO883697A NO883697D0 (en) 1986-12-22 1988-08-18 NEW PERTUSSIS TOXIN-DERIVED POLYPEPTIDE AND USE THEREOF.
FI892985A FI892985A (en) 1986-12-22 1989-06-19 NY POLYPEPTID OCH ANVAENDNING DAERAV.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8605513A SE468716B (en) 1986-12-22 1986-12-22 Novel peptide and immunologically active compounds

Publications (3)

Publication Number Publication Date
SE8605513D0 true SE8605513D0 (en) 1986-12-22
SE8605513L SE8605513L (en) 1988-06-23
SE468716B SE468716B (en) 1993-03-08

Family

ID=20366719

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8605513A SE468716B (en) 1986-12-22 1986-12-22 Novel peptide and immunologically active compounds
SE8700761A SE457353B (en) 1986-12-22 1987-02-24 PERTUSSISTOXIN ANTIGEN APPLIES IMMUNAL ANALYSIS TEST RATE, VACCINE COMPOSITION AND INTRADERMAL SKIN TEST COMPOSITION WITH THE SAME ANTIGEN

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8700761A SE457353B (en) 1986-12-22 1987-02-24 PERTUSSISTOXIN ANTIGEN APPLIES IMMUNAL ANALYSIS TEST RATE, VACCINE COMPOSITION AND INTRADERMAL SKIN TEST COMPOSITION WITH THE SAME ANTIGEN

Country Status (2)

Country Link
IE (1) IE873470L (en)
SE (2) SE468716B (en)

Also Published As

Publication number Publication date
SE8700761D0 (en) 1987-02-24
SE468716B (en) 1993-03-08
IE873470L (en) 1988-06-22
SE457353B (en) 1988-12-19
SE8700761L (en) 1988-06-23
SE8605513L (en) 1988-06-23

Similar Documents

Publication Publication Date Title
SE8800169L (en) NEW PEPTIDE DERIVATIVES, THEIR PREPARATION AND USE
DE69532760D1 (en) AGENTS FOR THE ADMINISTRATION OF ANTIGENS
MC2106A1 (en) AMINO ACID DERIVATIVES
FI932561A (en) Protein with intact epithelium and pharyngeal protein
ATE98376T1 (en) SYNTHETIC HTLV-III PEPTIDE COMPOSITIONS AND THEIR USE.
MC2103A1 (en) AMINO ACID DERIVATIVES
EP0284587A3 (en) Synthetic peptide antigens for the detection of hiv-1 infection
TR199802534T2 (en) Leptin (OB Protein) fragmanlar�
SE8901552L (en) ACID ADDITION SALTS OF AMIDATED TAURIN OR GLYCIN, THEIR PREPARATION AND USE
ES2081817T3 (en) POLYPEPTIDE WITH MAIN SEQUENCES REPEATED THAT ARE FIXED IN THE CELL.
DE3787657D1 (en) Amino acid derivatives.
BG97123A (en) DERIVATIVES OF HUMAN BILE SALTS, LIPASE AND PHARMACEUTICAL COMPOSITIONS BASED THEREOF
DK0707473T3 (en) Oral pharmaceutical compositions comprising a protein or peptide, an antibody and polymer beads
IT8521718A0 (en) PEPTIDE COMPOSITION USEFUL FOR THE PREPARATION OF VACCINES FOR MALARIA AND DIAGNOSTIC KITS FOR THE DETERMINATION OF MALARIA DISEASES.
ATE90108T1 (en) VASOCONSTRICTOR PEPTIDE.
ATE90359T1 (en) PEPTIDES.
SE8605513D0 (en) NEW PEPTID AND IMMUNOLOGICALLY ACTIVE ASSOCIATIONS
KR920700222A (en) Lyophilized peptide preparation
FI93843B (en) Method for producing an angiogenic factor
IT1217314B (en) SYNTHETIC NONAPEPTIDE WITH ADJUVANT ACTIVITY CAPABLE OF ENHANCING THE ANTI-CORPORAL RESPONSE IN VIVO
BG90414A (en) 2-AZABICYCLO (2,2,1)-HEPT-5-EN-2-ACETIC ACID AND ITS DERIVATIVES, METHOD OF PREPARATION AND THEIR APPLICATION
SE9000793L (en) SDK PEPTIDES, PROCEDURES FOR PREPARING THEM AND THERAPEUTIC COMPOSITIONS CONTAINING THEM
IT1186766B (en) METHOD FOR THE PREPARATION OF IMMUNOGLOBULINS FOR INTRAVENOUS USE
DE3780388D1 (en) FSH-STIMULATING PEPTIDE.
ATE27822T1 (en) HEXAPEPTIDE, PROCESSES FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8605513-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8605513-4

Format of ref document f/p: F